Evaluation of Lower Extremity Interventions in Individuals With Chronic Stroke
Evaluation of the Effects of Closed Kinetic Chain Exercises and Kinesio Taping on the Lower Extremity in Individuals With Chronic Stroke
1 other identifier
interventional
30
1 country
1
Brief Summary
This study aims to evaluate the effectiveness of closed kinetic chain (CKC) exercises and kinesio taping on knee joint proprioception, balance, functional performance, and quality of life in individuals with chronic stroke. Stroke often results in proprioceptive deficits and postural control impairments, which negatively impact rehabilitation outcomes. While CKC exercises are believed to enhance proprioceptive input through joint compression and sensory feedback, kinesio taping is used as a complementary intervention to support motor control and stability. The study will compare the effects of these two interventions to determine their potential roles in improving sensorimotor function and promoting functional independence in stroke rehabilitation. A total of 30 participants were enrolled in this study. Inclusion Criteria:
- Patients who had a stroke more than 6 months ago,
- Having a stable medical condition,
- Ability to understand simple instructions,
- Individuals with spasticity between grades 0-2 according to the Modified Ashworth Scale,
- Individuals who can walk independently or with assistive devices,
- Those who agree to participate and comply with the study procedures. Exclusion Criteria:
- Severe cognitive impairment (MMSE score \< 24),
- Orthopedic conditions that may cause knee pain during exercise,
- Other neurological conditions that may affect proprioception,
- Severe joint contracture,
- Refusal or unwillingness to participate in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedFirst Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
December 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedDecember 2, 2025
October 1, 2025
3 months
November 14, 2025
December 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of knee joint position sense
Knee joint position sense will be evaluated using active and passive joint position sense tests. Prior to testing, the limb will be passively moved 10 times to prepare for the movement. The Physiomaster mobile application will be used to measure the angular difference between the affected and unaffected knees at the end of the movement. Active joint position sense will be measured by asking participants to replicate a 45° knee flexion angle with their eyes closed. The angular error will be calculated. Passive joint position sense will be assessed by passively positioning the knee, then asking participants to estimate the angle after returning to the starting position. Repetitive flexion and extension movements will be performed, and error detection will be recorded. Placebo movements will be included in the evaluation.
2 months
Secondary Outcomes (4)
Berg Balance Scale (BBS)
2 months
Timed Up and Go Test (TUG)
2 months
10-Meter Walk Test (10MWT)
2 months
Stroke-Specific Quality of Life Scale (SS-QOL)
2 months
Study Arms (2)
the group engaged in closed kinetic chain exercises
EXPERIMENTALClosed kinetic chain exercises of the lower extremity are typically performed with the feet secured to a stable object that generates compressive forces at the hip, knee, and ankle joints. Participants will perform closed kinetic chain exercises in 40-minute sessions, twice a week for 8 weeks. Each exercise will be repeated 3 to 5 times, depending on the individual's strength .Exercises include: wall squats, forward and upward step-ups, side and upward step-ups, double-leg squats, bridges, and quadriceps isometric strengthening exercises.
Kinesiotaping Group (KB)
EXPERIMENTALKinesiotaping will be applied to increase proprioceptive awareness of the knee joint. Taping will be applied using the \*"Y" technique and \*"I" technique, focusing on medial and lateral support. The kinesio tape will remain in place for 3 days, followed by a 1-day break, and then reapplied. Tape changes will be performed by a physical therapist for a total of 8 weeks.
Interventions
Joint position sense will be assessed using active and passive joint position sense tests. Before starting the movement, the extremity will be moved ten times to prepare for movement. The "Physio Master" phone application will be used to measure the angle difference between the affected and unaffected knees at the end point of the movement. With the individual sitting upright with their back straight, knees flexed at 90 degrees, the participant's knee will be flexed to 45 degrees and the participant will be asked to repeat the same angle with their eyes closed. The error in angles (°) will be calculated. Passive position sense will be measured and recorded by passively moving the participant to the determined angle (15-30-45-60) and then asking them to estimate the angle upon returning to the starting position. Repeated flexion and extension will be performed to assess any errors in the movement. Placebo exercises will also be administered during the assessment. The test was repeated t
The Berg Balance Scale was developed primarily to assess postural control and is widely used in many rehabilitation settings. The 14 items in the scale assess expected balance during common activities of daily living, including standing and static sitting balance, as well as turning, picking up objects from the floor, and transfers. Scoring is typically done on a 5-point scale that assesses whether the patient can perform the task safely and independently for a specific time period. A score of 0 is given when the patient cannot perform the movement at all, and a score of 4 is given when the patient completes the movement independently. The maximum score is 56, with a score of 0-20 indicating impaired balance, 21-40 indicating acceptable balance, and 41-56 indicating good balance. The completion of the scale takes approximately 10 to 20 minutes. The Turkish validity and reliability study of the scale was conducted by Şahin et al. in 2008 on stroke patients.
It measures the time it takes for a patient to stand up from a chair, walk 3 meters, turn, and sit back down. The test time was recorded in seconds. The test was repeated three times, and the average time was recorded as a score. If necessary, the patient was allowed to perform the test using a walking aid. It is an objective clinical measurement used to assess functional mobility, dynamic balance, and fall risk in older individuals. It has also been shown to be a valid and reliable test in stroke patients.
This test is used to determine walking speed. Two to three trials will be conducted at both comfortable and maximum speeds of their choosing. Participants will be instructed to walk at a "normal comfortable speed" or "as fast as safely possible." No practice trials will be conducted, and participants will rest for at least 30 seconds between trials. Typical shoes, standard orthotics, and any necessary assistive devices will be worn. Participants will walk approximately 14 meters, including a 2-meter acceleration and deceleration zone. The time participants spend walking the middle 6 meters of this walkway will be measured with a stopwatch, from the moment their toes first pass the starting cone to the moment they first pass the finishing cone. Walking speed will be calculated for each trial.
Quality of life is also an important prognostic indicator for stroke and provides a broader definition of the disease. This scale consists of 49 items in 12 domains: mobility, energy, upper extremity functionality, work/productivity, mood, self-care, social roles, family roles, vision, language, thinking, and personality. SS-QOL items are assessed on a five-point Likert-type scale. Responses range from 1 (Strongly disagree) to 5 (Strongly agree). High scores on the scale indicate high quality of life, while low scores indicate low quality of life.
Eligibility Criteria
You may qualify if:
- Patients who had a stroke more than 6 months ago,
- Individuals with a medically stable condition,
- Ability to understand simple instructions,
- Individuals with spasticity graded between 0 and 2 according to the Modified Ashworth Scale,
- Individuals who can walk independently or with assistive devices,
- Individuals who agree to participate in the study and are able to comply with the study procedures.
You may not qualify if:
- Severe cognitive impairment (Mini-Mental Test score \< 24),
- Orthopedic conditions that may cause knee pain during exercise,
- Other neurological conditions that may affect proprioception,
- Severe joint contracture,
- Individuals who do not wish to voluntarily participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Özel İncirli Akademi Özel eğitim ve rehabilitasyon merkezi
Istanbul, Bakırköy, 34147, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Dilanur Ö Özkaraoğlu, Doctor Physiotherapist
Medipol University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master's Student
Study Record Dates
First Submitted
November 14, 2025
First Posted
December 2, 2025
Study Start
May 30, 2025
Primary Completion
August 30, 2025
Study Completion
December 30, 2025
Last Updated
December 2, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared. The study has not yet been completed. All data collected will be used solely for purposes approved by the ethics committee and will not be shared with third parties. Since no specific consent was obtained from participants for IPD sharing, data will not be shared in accordance with confidentiality and ethical principles.